Literature DB >> 6436337

Mycoplasma pneumoniae protein involved in the antibody response in human infection.

S Räisänen, J I Suni, A Vaheri.   

Abstract

Antigen from purified Mycoplasma pneumoniae organisms treated with Tween-80-ether was used in a solid phase enzyme immunoassay and compared with the conventional lipid containing complement fixation antigen for measuring antibodies in sera from patients with aseptic or bacterial meningitis or with apparent M pneumoniae infection. In immunoblotting of the enzyme immunoassay antigen, enzyme immunoassay positive sera detected a polypeptide at Mr = 180.000-200.000, while enzyme immunoassay negative sera whether positive or negative in the complement fixation test did not. These results indicate that the enzyme immunoassay antigen containing the high molecular weight polypeptide can be used to measure M pneumoniae antibodies more specifically than the conventional lipid containing complement fixation antigen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436337      PMCID: PMC498953          DOI: 10.1136/jcp.37.10.1129

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  23 in total

1.  Mycoplasma pneumoniae as a determinant of the Guillain-Barré syndrome.

Authors:  J C Steele; S Thanasophon; R M Gladstone; P C Fleming
Journal:  Lancet       Date:  1969-10-04       Impact factor: 79.321

2.  Antibody response in patients with acute pancreatitis to mycoplasma pneumoniae.

Authors:  P Leinikki; P Pantzar; H Tykkä
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Central nervous system complications of Mycoplasma pneumoniae infection.

Authors:  G Sterner; G Biberfeld
Journal:  Scand J Infect Dis       Date:  1969

5.  Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection.

Authors:  G Biberfeld
Journal:  Clin Exp Immunol       Date:  1971-02       Impact factor: 4.330

6.  Occlusion of brain capillaries by endothelial swelling in mycoplasma infections.

Authors:  E E Manuelidis; L Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

7.  Pericarditis and perimyocarditis associated with active Mycoplasma pneumoniae infection.

Authors:  M J Sands; J E Satz; W E Turner; L A Soloff
Journal:  Ann Intern Med       Date:  1977-05       Impact factor: 25.391

8.  Studies of PPLO infection. II. The neurotoxin of Mycoplasma neurolyticum.

Authors:  L Thomas; F Aleu; M W Bitensky; M Davidson; B Gesner
Journal:  J Exp Med       Date:  1966-12-01       Impact factor: 14.307

9.  Surface parasitism by Mycoplasma pneumoniae of respiratory epithelium.

Authors:  P C Hu; A M Collier; J B Baseman
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

10.  Studies of PPLO infection. IV. The neurotoxicity of intact mycoplasmas, and their production of toxin in vivo and in vitro.

Authors:  L Thomas; M W Bitensky
Journal:  J Exp Med       Date:  1966-12-01       Impact factor: 14.307

View more
  1 in total

1.  Reaction pattern of human anti-Mycoplasma pneumoniae antibodies in enzyme-linked immunosorbent assays and immunoblotting.

Authors:  E Jacobs; A Bennewitz; W Bredt
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.